BiotechTube
Home/Eyconis/Oliver Stauch, PhD
OS

Oliver Stauch, PhD

Co-Founder & Chief Operating Officer

Eyconis

Therapeutic Areas

OphthalmologyRetinal Diseases

Eyconis Pipeline

DrugIndicationPhase
UndisclosedWet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO), Geographic Atrophy (GA)Pre-clinical

Leadership Team at Eyconis

MB
Mark Bachleda, PharmD, MBA
Chief Executive Officer & Board Director
ET
Emmett T. Cunningham, Jr, MD, PhD, MPH
Co-Founder & Executive Chairman of the Board
View full Eyconis profile